We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
- Authors
Tanaka, Sota; Nagase, Satoru; Kaiho-Sakuma, Michiko; Nagai, Tomoyuki; Kurosawa, Hiroki; Toyoshima, Masafumi; Tokunaga, Hideki; Otsuki, Takeo; Utsunomiya, Hiroki; Takano, Tadao; Niikura, Hitoshi; Ito, Kiyoshi; Yaegashi, Nobuo
- Abstract
Background: Pelvic exenteration has attained an important role in the treatment of advanced or recurrent cervical cancer for obtaining a complete cure or longer disease-free survival. The purpose of this study was to evaluate patients undergoing pelvic exenteration and to determine the clinical features associated with outcome and survival. Methods: We retrospectively analyzed the records of 12 patients who underwent pelvic exenteration for uterine cervical cancer between July 2002 and August 2011. Results: Two patients had primary stage IVA cervical adenocarcinoma and 10 patients had recurrent cervical cancer. Eight patients underwent anterior pelvic exenteration, 3 patients underwent total pelvic exenteration, and 1 patient underwent posterior pelvic exenteration. With a median duration of follow-up of 22 months (range 3-116 months), 5 patients were alive without recurrence. Of 5 patients with no evidence of disease, 4 were recurrent or residual tumor, all of whom had common factors, such as a tumor size ≤30 mm, negative surgical margins, complete resection, and no lymph node involvement. The 5-year overall survival rate for 12 patients was 42.2 %. Ileus was the most common complication (42 %) and post-operative intestinal anastomosis leaks developed in 3 patients, but no ureteral anastomosis leaks occurred. Conclusions: Pelvic exenteration is a feasible surgical procedure in advanced and/or recurrent cervical cancer patients with no associated post-operative mortality, and the only therapeutic option for complete cure or long-term survival; however, post-operative complications frequently occur.
- Subjects
CERVICAL cancer treatment; HEALTH outcome assessment; PELVIC surgery; CANCER relapse; FOLLOW-up studies (Medicine); SURGICAL anastomosis; CANCER-related mortality
- Publication
International Journal of Clinical Oncology, 2014, Vol 19, Issue 1, p133
- ISSN
1341-9625
- Publication type
Article
- DOI
10.1007/s10147-013-0534-9